Expansion momentum Strategic investments to expand production capacity at Avène and a new industrial master plan indicate increased demand for high-volume dermocosmetics and finished goods manufacturing services.

Integration opportunities Active partnerships across biologics, AI-driven drug discovery, and digital transformation with Salesforce and Olyzon create openings for outsourced product development, clinical supply optimization, and omnichannel go-to-market support.

Global footprint Presence in 120 countries with a strong international revenue share suggests opportunities to scale contract manufacturing, regulatory support, and distributed marketing collaborations beyond France.

Sustainability edge Excellence in CSR recognized by ECOCERT and a foundation-owned ownership structure highlight alignment with sustainability-minded buyers seeking responsible supply chains and impact-driven partnerships.

Dermocosmetics leadership Being the second-largest dermocosmetics lab and market leader in OTC pharmacies creates cross-sell potential for complementary brands (Avene, Klorane, Ducray, Rene Furterer) and expansion into new dermocosmetic SKUs and private-label opportunities.